This Inter-Agency Agreement between the National Heart, Lung, and Blood Institute (NHLBI) and support the Systolic Blood Pressure Intervention Trial (SPRINT), a multicenter clinical trial to determine whether maintaining blood pressure levels lower than current recommendations further reduces the risk of cardiovascular disease, chronic kidney disease, dementia and age-related cognitive decline.

Agency
National Institute of Health (NIH)
Type
NIH Inter-Agency Agreements (Y01)
Project #
AHL13002001-1-0-1
Application #
9173548
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2015
Total Cost
Indirect Cost
Name
National Heart, Lung, and Blood Institute
Department
Type
DUNS #
City
State
Country
Zip Code